Showing results (61-70 of 206) with videos related to
Sort By:
Pageof 21
Rheumatology (Oxford, England)|February 13, 2019
Routine musculoskeletal ultrasound findings impact diagnostic decisions maximally in autoantibody-seronegative early arthritis patientsKundan Iqbal, Dennis W Lendrem, Ben Hargreaves, et al.Rheumatology (Oxford, England)|March 8, 2022
The role of comorbidities alongside patient and disease characteristics in long-term disease activity in RA using UK inception cohort dataAmanda D Busby, James Wason, Arthur G Pratt, et al.Therapeutic Advances in Musculoskeletal Disease|June 12, 2020
Lack of association between clinical and ultrasound measures of disease activity in rheumatoid arthritis remissionKenneth F Baker, Ben Thompson, Dennis W Lendrem, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 29, 2014
A negative feedback loop mediated by STAT3 limits human Th17 responsesHarriet A Purvis, Amy E Anderson, David A Young, et al.Arthritis Research & Therapy|December 6, 2012
Disease activity and cognition in rheumatoid arthritis: an open label pilot studyGraham Raftery, Jiabao He, Ruth Pearce, et al.Arthritis Research & Therapy|September 3, 2011
Integrated safety in tocilizumab clinical trialsMichael H Schiff, Joel M Kremer, Angelika Jahreis, et al.Clinical Proteomics|August 13, 2021
Robust optimization of SWATH-MS workflow for human blood serum proteome analysis using a quality by design approachEdith Serrano-Blesa, Andrew Porter, Dennis W Lendrem, et al.Arthritis Research & Therapy|February 9, 2012
Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow upMark Houseman, Catherine Potter, Nicola Marshall, et al.Arthritis and Rheumatism|September 29, 2011
Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohortDarren Plant, Rita Prajapati, Kimme L Hyrich, et al.Drug Discovery Today|December 14, 2019
Schrödinger's pipeline and the outsourcing of pharmaceutical innovationPeter McMeekin, Dennis W Lendrem, B Clare Lendrem, et al.Pageof 21